Irbesartan Patent Expiration
Irbesartan was first introduced by Sanofi Aventis Us Llc
Irbesartan Patents
Given below is the list of patents protecting Irbesartan, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Avapro | US6342247 | Pharmaceutical compositions containing irbesartan |
Jun 07, 2015
(Expired) | Sanofi Aventis Us |
Avapro |
US6342247 (Pediatric) | Pharmaceutical compositions containing irbesartan |
Dec 07, 2015
(Expired) | Sanofi Aventis Us |
Try Our Curated Drug Screens
Irbesartan Generics
Several generic applications have been filed for Irbesartan. The first generic version for Irbesartan was by Teva Pharmaceuticals Usa and was approved on Mar 30, 2012. And the latest generic version is by Ipca Laboratories Ltd and was approved on May 22, 2024.
Given below is the list of companies who have filed for Irbesartan generic.
1. AJANTA PHARMA LTD
Ajanta Pharma Ltd has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
75MG | tablet | Discontinued | ORAL | N/A | Dec 10, 2015 |
150MG | tablet | Discontinued | ORAL | N/A | Dec 10, 2015 |
300MG | tablet | Discontinued | ORAL | N/A | Dec 10, 2015 |
2. ALEMBIC PHARMS LTD
Alembic Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Alembic Pharms Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
75MG | tablet | Prescription | ORAL | AB | Oct 15, 2012 |
150MG | tablet | Prescription | ORAL | AB | Oct 15, 2012 |
300MG | tablet | Prescription | ORAL | AB | Oct 15, 2012 |
3. AMNEAL PHARMS
Amneal Pharmaceuticals Of New York Llc has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Amneal Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
75MG | tablet | Prescription | ORAL | AB | Apr 17, 2018 |
150MG | tablet | Prescription | ORAL | AB | Apr 17, 2018 |
300MG | tablet | Prescription | ORAL | AB | Apr 17, 2018 |
4. APOTEX INC
Apotex Inc has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Apotex Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
75MG | tablet | Discontinued | ORAL | N/A | Oct 15, 2012 |
150MG | tablet | Discontinued | ORAL | N/A | Oct 15, 2012 |
300MG | tablet | Discontinued | ORAL | N/A | Oct 15, 2012 |
5. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
75MG | tablet | Prescription | ORAL | AB | Sep 27, 2012 |
300MG | tablet | Prescription | ORAL | AB | Sep 27, 2012 |
150MG | tablet | Prescription | ORAL | AB | Sep 27, 2012 |
6. CHARTWELL MOLECULAR
Chartwell Molecular Holdings Llc has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Chartwell Molecular.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
300MG | tablet | Prescription | ORAL | AB | Nov 14, 2012 |
150MG | tablet | Prescription | ORAL | AB | Nov 14, 2012 |
75MG | tablet | Prescription | ORAL | AB | Nov 14, 2012 |
7. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
300MG | tablet | Discontinued | ORAL | N/A | Sep 27, 2012 |
150MG | tablet | Discontinued | ORAL | N/A | Sep 27, 2012 |
75MG | tablet | Discontinued | ORAL | N/A | Sep 27, 2012 |
8. HETERO LABS LTD V
Hetero Labs Ltd Unit V has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd V.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
75MG | tablet | Prescription | ORAL | AB | Sep 27, 2012 |
150MG | tablet | Prescription | ORAL | AB | Sep 27, 2012 |
300MG | tablet | Prescription | ORAL | AB | Sep 27, 2012 |
9. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Hikma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
150MG | tablet | Discontinued | ORAL | N/A | Oct 15, 2012 |
75MG | tablet | Discontinued | ORAL | N/A | Oct 15, 2012 |
300MG | tablet | Discontinued | ORAL | N/A | Oct 15, 2012 |
10. HISUN PHARM HANGZHOU
Hisun Pharmaceutical (hangzhou) Co Ltd has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Hisun Pharm Hangzhou.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
75MG | tablet | Prescription | ORAL | AB | Jun 14, 2016 |
300MG | tablet | Prescription | ORAL | AB | Jun 14, 2016 |
150MG | tablet | Prescription | ORAL | AB | Jun 14, 2016 |
11. IPCA LABS LTD
Ipca Laboratories Ltd has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Ipca Labs Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
75MG | tablet | Prescription | ORAL | AB | May 22, 2024 |
150MG | tablet | Prescription | ORAL | AB | May 22, 2024 |
300MG | tablet | Prescription | ORAL | AB | May 22, 2024 |
12. JUBILANT GENERICS
Jubilant Generics Ltd has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Jubilant Generics.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
75MG | tablet | Prescription | ORAL | AB | Feb 23, 2015 |
150MG | tablet | Prescription | ORAL | AB | Feb 23, 2015 |
300MG | tablet | Prescription | ORAL | AB | Feb 23, 2015 |
13. LUPIN LTD
Lupin Ltd has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
75MG | tablet | Prescription | ORAL | AB | Oct 15, 2012 |
150MG | tablet | Prescription | ORAL | AB | Oct 15, 2012 |
300MG | tablet | Prescription | ORAL | AB | Oct 15, 2012 |
14. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
300MG | tablet | Prescription | ORAL | AB | Oct 3, 2012 |
150MG | tablet | Prescription | ORAL | AB | Oct 3, 2012 |
75MG | tablet | Prescription | ORAL | AB | Oct 3, 2012 |
15. PRINSTON INC
Prinston Pharmaceutical Inc has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Prinston Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
75MG | tablet | Prescription | ORAL | AB | Sep 27, 2012 |
150MG | tablet | Prescription | ORAL | AB | Sep 27, 2012 |
300MG | tablet | Prescription | ORAL | AB | Sep 27, 2012 |
16. SANDOZ
Sandoz Inc has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Sandoz.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
300MG | tablet | Prescription | ORAL | AB | Sep 27, 2012 |
75MG | tablet | Prescription | ORAL | AB | Sep 27, 2012 |
150MG | tablet | Prescription | ORAL | AB | Sep 27, 2012 |
17. SCIEGEN PHARMS INC
Sciegen Pharmaceuticals Inc has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
150MG | tablet | Prescription | ORAL | AB | Dec 7, 2015 |
75MG | tablet | Prescription | ORAL | AB | Dec 7, 2015 |
300MG | tablet | Prescription | ORAL | AB | Dec 7, 2015 |
18. TEVA PHARMS
Teva Pharmaceuticals Usa has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Teva Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
300MG | tablet | Prescription | ORAL | AB | Mar 30, 2012 |
150MG | tablet | Prescription | ORAL | AB | Mar 30, 2012 |
75MG | tablet | Prescription | ORAL | AB | Mar 30, 2012 |
19. UNICHEM
Unichem Laboratories Ltd has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Unichem.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
150MG | tablet | Prescription | ORAL | AB | Dec 7, 2015 |
75MG | tablet | Prescription | ORAL | AB | Dec 7, 2015 |
300MG | tablet | Prescription | ORAL | AB | Dec 7, 2015 |
20. UPSHER SMITH LABS
Upsher Smith Laboratories Llc has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Upsher Smith Labs.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
300MG | tablet | Discontinued | ORAL | N/A | Sep 27, 2012 |
75MG | tablet | Discontinued | ORAL | N/A | Sep 27, 2012 |
150MG | tablet | Discontinued | ORAL | N/A | Sep 27, 2012 |
21. WATSON LABS INC
Watson Laboratories Inc has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Watson Labs Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
150MG | tablet | Discontinued | ORAL | N/A | Oct 12, 2012 |
300MG | tablet | Discontinued | ORAL | N/A | Oct 12, 2012 |
75MG | tablet | Discontinued | ORAL | N/A | Oct 12, 2012 |
22. ZYDUS PHARMS USA INC
Zydus Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Irbesartan. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
75MG | tablet | Prescription | ORAL | AB | Sep 27, 2012 |
150MG | tablet | Prescription | ORAL | AB | Sep 27, 2012 |
300MG | tablet | Prescription | ORAL | AB | Sep 27, 2012 |